Bing

SEARCH HISTORY

They set a “strong-buy” rating and a $1.45 price target on the stock. Shares of Hemispherx BioPharma (NYSE:HEB) opened at 0.258 on Thursday. Hemispherx BioPharma has a 52 week low of $0.210 and a 52 …
wkrb13.com · 5/14/2015
Shares of Hemispherx BioPharma (NYSE:HEB) traded up 0.7090% during mid-day trading on Wednesday, hitting $0.2699. 720,027 shares of the company’s stock traded hands. Hemispherx BioPharma has a one year low of $0.2100 and a one year high …
Mideast Times · 5/13/2015
They set a “strong-buy” rating and a $1.45 price target on the stock. Hemispherx BioPharma (NYSE:HEB) opened at 0.268 on Wednesday. Hemispherx BioPharma has a 1-year low of $0.210 and a 1-year high of $0.400. The stock has a 50-day moving …
sleekmoney.com · 5/13/2015
More from Bing News
Chloe's Soft Serve Fruit Pops are now available in more than 2,000 grocery stores nationwide including HEB, Kroger, Fresh & Easy Markets, Mrs. Greens Markets, Bay Area Whole Foods, Wegmans and at the Chloe's …
Financial Content · 1 day ago
Tickets are available through all HEB stores at the customer service desk ... Elizabeth has held the role of Diana Morales in A Chorus Line, she has choreographed the Miss Stock Show and Rodeo, the Miss Pan …
Guardian LV · 5/15/2015
That's the big catalyst. Mary Jo D. writes, "Your article may be enough to lower Hemispherx Biopharma's (HEB) stock price to where I'll want to add to my holdings. New price target is $3. That's a pretty fair value from my due diligence. Plus, if the ...
The Street · ByAdam Feuerstein · 2/6/2015
Compensation and benefit expenses increased $2.17 million (or 94.3%) to $4.47 million with less than half being paid in cash and the remainder being paid with the issuance of stock and options ... Safeway and HEB. Internationally, Marley Coffee continues ...
Yahoo Finance · 5/11/2015
Stock analysts at Midtown Partners initiated coverage on shares of Hemispherx BioPharma (NYSE:HEB) in a report issued on Thursday. The firm set a “strong-buy” rating and a $1.45 price target on the stock. Hemispherx BioPharma (NYSE:HEB) …
Ticker Report · 4/2/2015
Our common stock is listed on the NYSE MKT under the ticker symbol "HEB". Sales of shares of our common stock under this prospectus supplement and the accompanying prospectus, if any, may be made by any method permitted by law deemed to be …
Benzinga · ByPaul Quintaro · 3/6/2015
Hemispherix Biopharma (NYSEMKT:HEB) is awaiting news from the FDA on its NDA application for Ampligen as a treatment for Chronic Fatigue Syndrome. The stock has soared from about $0.38 in March to a high of $4.54. Ampligen has received rave …
Seeking Alpha · ByDavid White · 6/24/2009